Zevra Therapeutics, Inc. (ZVRA)
9.99
-0.19
(-1.87%)
USD |
NASDAQ |
Oct 02, 16:00
9.975
-0.02
(-0.15%)
Pre-Market: 20:00
Zevra Therapeutics Gross Profit Margin (Quarterly) : 95.36% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 95.36% |
| March 31, 2026 | 93.75% |
| December 31, 2025 | 94.48% |
| September 30, 2025 | 94.04% |
| June 30, 2025 | 45.93% |
| March 31, 2025 | 85.49% |
| December 31, 2024 | 61.55% |
| September 30, 2024 | -47.90% |
| June 30, 2024 | -50.17% |
| March 31, 2024 | 4.67% |
| December 31, 2023 | 78.92% |
| September 30, 2023 | 92.88% |
| June 30, 2023 | 91.09% |
| March 31, 2023 | 93.58% |
| Date | Value |
|---|---|
| December 31, 2022 | 84.08% |
| September 30, 2022 | 81.25% |
| June 30, 2022 | 82.15% |
| March 31, 2022 | 98.16% |
| December 31, 2021 | 95.24% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 91.12% |
| March 31, 2021 | 91.22% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 90.71% |
| March 31, 2020 | 64.82% |
| December 31, 2019 | -46.80% |
| September 30, 2019 | 90.61% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Innoviva, Inc. | 73.64% |
| Johnson & Johnson | 68.73% |
| Ligand Pharmaceuticals, Inc. | 82.24% |
| Collegium Pharmaceutical, Inc. | 55.18% |
| Xeris Biopharma Holdings, Inc. | 83.47% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 33.79% |
| Return on Assets | 20.11% |
| Return on Invested Capital | 27.47% |
| Profit Margin (Quarterly) | 21.16% |
| Operating Margin (Quarterly) | 42.30% |
| Return on Net Operating Assets | 161.7% |